More Intelligence, Better Care. Seeking for collaboration.
Launched in 2015, Airdoc is leading the way in the field of artificial intelligence in chronic disease management and myopia prevention. Its SaMD product is a certified product for the global use of artificial intelligence retinal imaging to identify lesions.
In 2023, our Airdoc-AIFUNDUS (1.0) was certified by the European Union Medical Device Regulation ("CE MDR") and can officially enter the market of 27 EU member states, including Belgium, Germany, Italy, France, etc., and AI-FUNDUSCAMERA-P has obtained regulatory approval or registration in Indonesia, South Africa, Saudi Arabia, the United Arab Emirates and Thailand.
In April 2023, our AI-FUNDUSCAMERA-P and myopia treatment product won the “Special Commendation Gold Awards” at the Salon International des Inventions de Genève (International Exhibition of Inventions in Geneva), signifying widespread recognition and affirmation of our products among global inventors and professionals.
At ARVO, we are looking for researchers and partners from around the world to collaborate.
Brands: Airdoc